keyword
MENU ▼
Read by QxMD icon Read
search

asd closure device

keyword
https://read.qxmd.com/read/30759074/comparison-of-remifentanil-based-fast-track-and-fentanyl-based-routine-cardiac-anesthesia-for-intraoperative-device-closure-of-atrial-septal-defect-asd-in-pediatric-patients
#1
Qing Huang, Lan-Ying Lin, Xian-Zhong Lin
BACKGROUND The aim of this study was to evaluate the effectiveness and safety of remifentanil-based fast-track anesthesia for intraoperative device closure of atrial septal defects (ASDs). MATERIAL AND METHODS The clinical data of 152 pediatric patients who received intraoperative device closure of ASD in our hospital from January 2015 to December 2017 were retrospectively analyzed. Patients were divided into 2 groups: group F (remifentanil-based fast-track anesthesia group, n=72) and group C (fentanyl-based routine anesthesia group, n=80)...
February 13, 2019: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://read.qxmd.com/read/30719850/a-randomized-controlled-multi-center-trial-of-the-efficacy-and-safety-of-the-occlutech-figulla-flex-ii-occluder-compared-to-the-amplatzer-septal-occluder-for-transcatheter-closure-of-secundum-atrial-septal-defects
#2
Damien Kenny, Andreas Eicken, Ingo Dähnert, Younes Boudjemline, Horst Sievert, Martin Be Schneider, Tommaso Gori, Ziyad M Hijazi
AIMS: The aim of this study was to compare the efficacy and safety of the Occlutech Figulla Flex II Occluder (OFFII) with the Amplatzer Septal Occluder (ASO) in patients > 8kg undergoing transcatheter ASD closure. METHODS AND RESULTS: Randomized, controlled, multi-center prospective clinical trial with randomization 2:1 in favor of the OFFII. Primary efficacy endpoint was the rate of successful device placement and defect closure without major complications at hospital discharge...
February 1, 2019: Catheterization and Cardiovascular Interventions
https://read.qxmd.com/read/30719342/serum-nickel-and-titanium-levels-after-transcatheter-closure-of-atrial-septal-defects-with-amplatzer-septal-occluder
#3
Ozlem Elkiran, Cemsit Karakurt, Gulendam Kocak, Cagatay Taskapan
Introduction: There is a concern about release of nickel and titanium after implantation of nitinol-containing devices. Objective: To evaluate serum nickel and titanium release after implantation of Amplatzer occluder. Materials and methods: In 38 pediatric patients with no history of nickel sensitivity, blood samples were drawn 24 hours before and 24 hours, 1, 3, 6, and 12 months after implantation. Nickel and titanium concentrations were measured by atomic absorption spectrophotometry...
2019: Cardiology Research and Practice
https://read.qxmd.com/read/30714327/strategy-of-treating-secundum-atrial-septal-defect-not-referred-to-percutaneous-closure
#4
Fei Zhang, Yifeng Yang, Qin Wu, Wancun Jin, Haisong Bu, Sijie Wu, Tianli Zhao, Shijun Hu
OBJECTIVE: To evaluate safety and effectiveness of intraoperative device closure for secundum atrial septal defect (ASD) not referred to percutaneous closure. DESIGN AND PATIENTS: From April 2010 to December 2018, 231 secundum ASD children (≤14 years) directly recommended to surgical repair were enrolled in this study. These patients were divided into two groups according to the parents' choice based on surgeons' recommendation. Follow-up evaluations were adopted at 2 weeks, 3 months, 6 months, and 12 months after the procedure and yearly thereafter...
February 4, 2019: Congenital Heart Disease
https://read.qxmd.com/read/30700633/endothelialization-of-an-amplatzer-septal-occluder-device-6-months-post-implantation-is-this-enough-time-an-in-vivo-angioscopic-assessment
#5
Yasuhiro Tanabe, Yukio Sato, Masaki Izumo, Yuki Ishibashi, Takumi Higuma, Tomoo Harada, Yoshihiro J Akashi
The current guidelines recommend a minimum of 6 months of antithrombotic and antibiotic prophylaxis following septal occluding device placement for transcatheter closure of atrial septal defect. Full neoendothelialization is thought to be completed within 6 months of device implantation; however, there is no method available that can assess the level of neoendothelialization in vivo. This report therefore evaluates endothelialization in vivo and demonstrates that 6 months of postimplantation prophylactic therapy may not provide sufficient time for adequate endothelialization...
February 2019: Journal of Invasive Cardiology
https://read.qxmd.com/read/30694870/endoscopic-closure-of-esophagopleural-fistula-with-amplatzer-atrial-septal-defect-closure-device
#6
Praveen Guturu, Mohammad Bilal, Umamahesh Rangasetty, Ikenna Okereke, Sreeram Parupudi
No abstract text is available yet for this article.
February 2019: American Journal of Gastroenterology
https://read.qxmd.com/read/30680882/wire-frame-integrity-of-patch-like-gore-devices-following-atrial-septal-defect-closure
#7
R Kubicki, K Fingerhut, M Uhl, J Hummel, R Höhn, K Reineker, T Fleck, B Stiller, J Grohmann
OBJECTIVES: To assess the structural integrity of the patch-like Gore Septal Occluder (GSO) used for device closure of secundum-type atrial septal defects (ASD II) in pediatric patients. BACKGROUND: GSO has shown to be effective and safe for ASD device closure in children and adolescents. METHODS: Single-center, retrospective mid- to long-term follow-up of all children and adolescents with a GSO in situ (≥12 months). Periprocedural data and follow-up data were evaluated, including chest X-rays to assess the GSO's wire-frame morphology...
January 24, 2019: Catheterization and Cardiovascular Interventions
https://read.qxmd.com/read/30627291/combined-percutaneous-procedure-in-patient-with-lutembacher-syndrome-a-case-report-and-real-world-experience-review
#8
Quang Tan Phan, Hieu Lan Nguyen, Tai Duc Le, WangSoo Lee, HoYoun Won, SeungYong Shin, Saima Sharmin, Truong Quang Nguyen, SangWook Kim
Even cardiac surgery has been accepted as the standard therapy for Lutembacher syndrome, a combination of congenital ostium secundum atrial septal defect (ASD) and acquired mitral valve stenosis (MVS), it also owns many limitations and disadvantages. Therefore, seeking for a less invasive therapy with the same efficacy may be worthwhile. Thanks to the development in technology and experience gaining in cardiovascular intervention, the combination of the two proved effective procedures, including percutaneous MVS treatment using balloon valvuloplasty and percutaneous ASD closure using atrial septal occluders, can be utilized as an attractive alternative therapy for these conditions...
December 2018: Cardiology Research
https://read.qxmd.com/read/30607441/transcatheter-closure-of-atrial-septal-defects-comparable-experience-and-outcomes-between-developing-and-developed-countries
#9
Ahmad Almanla, Fatme Charafeddine, Mohamad Abutaqa, Hala Mustafa, Anas Tabbakh, Haytham Bou Hussein, Fadi Sawaya, Issam El-Rassi, Mariam Arabi, Ziad Bulbul, Fadi Bitar
Atrial septal defect (ASD) is one of the most common congenital heart defects. Transcatheter device closure of ASDs is safe and effective with most of the reported data being described from developed countries. To evaluate the short and mid-term results and experience of device closure of ASDs at a tertiary center in a developing country and compare it to that from developed countries. Retrospective study based on data collection from all patients who have undergone transcatheter percutaneous device closure for ASD from January 2005 until December 2017 at the Children's Heart Center at the American University of Beirut, Medical Center, Lebanon...
January 3, 2019: Pediatric Cardiology
https://read.qxmd.com/read/30598605/atrial-septal-defect-occluder-devices-for-closure-of-tracheoesophageal-fistulas-are-they-safe
#10
Franco Coppola
No abstract text is available yet for this article.
January 2019: Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology
https://read.qxmd.com/read/30591738/short-term-outcomes-after-surgical-versus-trans-catheter-closure-of-atrial-septal-defects-a-study-from-iran
#11
Behnam Askari, Hamid Soraya, Nasim Ayremlu, Mitra Golmohammadi
Objectives: Atrial Septal Defect (ASD) accounts for 10% of congenital cardiac defects. The purpose of this retrospective study was to compare the short-term outcomes of surgical versus trans catheter closure of secundum atrial septal defect. Methods: This is a single-center retrospective cohort study in patients who had surgical or trans catheter ASD closure. ASD closure outcomes such as hospital cost, length of hospital and ICU stay, residual ASDs, complications, readmission, hospital and three month mortality were recorded and compared...
December 2018: The Egyptian heart journal: (EHJ): official bulletin of the Egyptian Society of Cardiology
https://read.qxmd.com/read/30591737/immediate-and-short-term-effects-of-percutaneous-atrial-septal-defect-device-closure-on-cardiac-electrical-remodeling-in-children
#12
Alaa Mahmoud Roushdy, Hebatalla Attia, Heba Nossir
Background: The beneficial effects of atrial septal defect (ASD) device closure on electrical cardiac remodeling are well established. The timing at which these effects starts to take place has yet to be determined. Objectives: To determine the immediate and short term effects of ASD device closure on cardiac electric remodeling in children. Methods: 30 pediatric patients were subjected to 12 lead Electrocardiogram immediately before ASD device closure, 24 h post procedure, 1 and 6 months after...
December 2018: The Egyptian heart journal: (EHJ): official bulletin of the Egyptian Society of Cardiology
https://read.qxmd.com/read/30570151/assessment-of-the-right-and-left-atrial-functions-at-midterm-after-surgical-and-device-atrial-septal-defect-closure-a-2-dimensional-speckle-tracking-echocardiographic-study
#13
Alimohammad Hajizeinali, Mohammadreza Iri, Ali Hosseinsabet
OBJECTIVES: The available literature lacks data on the comparison of the functions of the right atrium (RA) and left atrium (LA) between surgical atrial septal defect (ASD) closure and percutaneous device ASD closure at follow-up durations of longer than 1 year. We sought to evaluate the RA and LA functions in patients who underwent surgical or device ASD closure between 1 and 5 years postprocedurally. METHODS: The study population included 30 patients who underwent device ASD closure and 30 who underwent surgical ASD closure, who were matched for the procedural time, age, and sex, in addition to 30 control participants...
December 20, 2018: Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine
https://read.qxmd.com/read/30550803/fracture-of-a-transcatheter-atrial-septal-defect-occluder-device-causing-mitral-valve-perforation
#14
Raphael S Werner, René Prêtre, Francesco Maisano, Markus J Wilhelm
Transcatheter atrial septal defect (ASD) device closure has gained increasing popularity over the past decades due to shorter hospital stay and the absence of skin scars. However, concern about the seriousness of device-related complications is accumulating. We report a case of device fracture in a young asymptomatic woman almost 4 years after percutaneous secundum ASD closure, resulting in mitral valve perforation. Subsequently, elective surgical removal of the device and mitral valve reconstruction was performed...
December 11, 2018: Annals of Thoracic Surgery
https://read.qxmd.com/read/30541025/simultaneous-operative-repair-of-pectus-excavatum-and-concurrent-congenital-heart-defects
#15
Guangxian Yang, Xicheng Deng, Yifeng Yang, Ni Yin, Jinhua Wang, Pingbo Liu
OBJECTIVES: The aim of this study is to describe an effective surgical strategy for the treatment of children with pectus excavatum (PE) and concurrent congenital heart defect (CHD). METHODS: We retrospectively reviewed the medical records of all children (n = 16) who underwent simultaneous repair of PE with concurrent CHD at the Hunan Children's Hospital from July 2007 to December 2017. Among them, 7 patients had a simple atrial septal defect (ASD); 4 patients had a simple ventricular septal defect (VSD); 3 patients had both VSD and ASD; 1 patient had VSD, ASD and patent ductus arteriosus; and 1 patient had VSD complicated by pulmonary hypertension...
December 11, 2018: Interactive Cardiovascular and Thoracic Surgery
https://read.qxmd.com/read/30504733/transcatheter-device-closure-of-atrial-septal-defects-guided-completely-by-transthoracic-echocardiography-a-single-cardiac-center-experience-with-152-cases
#16
Qiang Chen, Hua Cao, Gui Can Zhang, Liang Wan Chen, Heng Lu, Lin Li Yu
OBJECTIVE: This study aimed to assess the safety and feasibility of transcatheter device closure of atrial septal defects (ASDs) guided completely by transthoracic echocardiography (TTE). METHODS: A total of 152 patients underwent transcatheter device closure of ASDs guided completely by TTE in our center from September 2014 to June 2017. We used routine delivery sheaths during the procedure and then closed the ASDs by releasing a domestic occluder. RESULTS: The closure was successful in 150 patients, and surgical repair was required in two patients...
December 2018: Anatolian Journal of Cardiology
https://read.qxmd.com/read/30498690/antiplatelet-therapy-in-valvular-and-structural-heart-disease-interventions
#17
REVIEW
Annunziata Nusca, Edoardo Bressi, Iginio Colaiori, Marco Miglionico, Germano Di Sciascio
Transcatheter interventions for valvular and structural heart diseases are rapidly expanding due to greater operators' experience and development of new generation devices associated with increased procedural safety. They represent the standard strategy for patients with prohibitive risk for open surgery. These procedures are associated with a significant occurrence of both thrombotic and bleeding complications, thus in this setting, even more than in other percutaneous procedures, the balance between thrombotic and bleeding risk is critical...
October 2018: Cardiovascular Diagnosis and Therapy
https://read.qxmd.com/read/30449418/state-of-the-art-atrial-septal-defect-closure-devices-for-congenital-heart
#18
REVIEW
Michael L O'Byrne, Daniel S Levi
This article describes current devices and indications for transcatheter device closure of atrial septal defect (TC-ASD) and patent foramen ovale in children and young adults. TC-ASD has a proven record of efficacy and safety, but device erosion raises questions about the relative safety of TC-ASD versus operative open heart surgical ASD closure. New devices for ASD closure with properties to reduce risk of erosion are being developed. Recent studies demonstrating superiority of patent foramen ovale device closure over medical therapy for cryptogenic stroke may lead to changes in practice for structural/interventional cardiologists...
January 2019: Interventional Cardiology Clinics
https://read.qxmd.com/read/30444273/a-new-perspective-of-migraine-symptoms-in-patients-with-congenital-heart-defect
#19
Yinglu Liu, Sulei Li, Rongfei Wang, Xun Han, Min Su, Xiutang Cao, Guangyi Wang, Feng Cao, Shengyuan Yu
OBJECTIVE: To investigate the association between congenital heart defects (CHDs) and migraine and evaluate the efficacy of transcatheter defect closure from a new perspective. METHODS: The patients with CHDs who underwent transcatheter defect closure were screened in the medical database of Chinese PLA General Hospital from January 2006 to January 2017. The assessment included basic admission information, the 3-item ID Migraine Screener, and a detailed questionnaire administered by telephone or in an outpatient clinic...
November 2018: Headache
https://read.qxmd.com/read/30419611/feasibility-safety-and-midterm-follow-up-of-patients-after-nonsurgical-closure-of-atrial-septal-defects-using-very-large-40-46-mm-nitinol-septal-occluders
#20
Kothandam Sivakumar, Bijesh Viswambaran, Sudipta Bhattacharjya
OBJECTIVES: To study the feasibility of closure of large atrial septal defects (ASDs) using occluder devices >38 mm and assess the midterm complications. BACKGROUND: Feasibility and safety of large occluders >38 mm and their follow-up are largely unknown. METHODS: All patients with ASDs closed using devices >38 mm were retrospectively analyzed. Since outcome of patients receiving 40 mm devices were known before, patients receiving 40 mm devices were compared with those receiving 42-46 mm devices on demographic, hemodynamic parameters and procedural characteristics...
November 12, 2018: Catheterization and Cardiovascular Interventions
keyword
keyword
158430
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"